Please enable JavaScript to continue using this application.

Compare $DMRA vs $ORIC | Chartloom

Compare

$DMRA vs $ORIC

Damora Therapeutics Inc · Oric Pharmaceuticals Inc

DMRA

Damora Therapeutics Inc

ORIC

Oric Pharmaceuticals Inc

Compare $DMRA vs $ORIC

Comparing Damora Therapeutics Inc and Oric Pharmaceuticals Inc

DMRADamora Therapeutics Inc

ORICOric Pharmaceuticals Inc

DMRADamora Therapeutics Inc

Market cap

$1.30B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-17.4%

52W performance

-17.4%

FCF yield

-3.4%

ORICOric Pharmaceuticals Inc

Market cap

$1.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

46.8%

52W performance

-16.0%

FCF yield

-9.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DMRA

ORIC

Detailed metrics comparison

DMRA

Damora Therapeutics Inc

ORIC

Oric Pharmaceuticals Inc

Market Cap

DMRA$1.30B

ORIC$1.24B

Enterprise Value

DMRA$757M

ORIC$1.20B

Price

DMRA$21.08

ORIC$11.99

P/E Ratio

DMRAN/A

ORICN/A

P/S Ratio

DMRA0.00x

ORIC0.00x

EV/Sales

DMRA0.00x

ORIC0.00x

EV/EBITDA

DMRA0.00x

ORIC0.00x

P/B Ratio

DMRA2.47x

ORIC3.32x

P/FCF Ratio

DMRAN/A

ORICN/A

EV/FCF

DMRA-17.00x

ORIC-10.72x

PEG Ratio

DMRAN/A

ORICN/A

Forward P/E (NTM)

DMRAN/A

ORICN/A

Forward P/S (NTM)

DMRAN/A

ORICN/A

Revenue (TTM)

DMRA$0

ORIC$0

Revenue Growth (YoY)

DMRAN/A

ORICN/A

Forward Rev Growth

DMRA346.9%

ORIC1520.7%

Gross Margin (TTM)

DMRA0.0%

ORIC0.0%

Operating Margin (TTM)

DMRA0.0%

ORIC0.0%

EBITDA Margin (TTM)

DMRA0.0%

ORIC0.0%

Net Margin (TTM)

DMRA0.0%

ORIC0.0%

FCF Margin (TTM)

DMRAN/A

ORICN/A

Net Income (TTM)

DMRA$-265M

ORIC$-140M

FCF (TTM)

DMRA$-45M

ORIC$-112M

EPS (TTM)

DMRA-$4.34

ORIC-$1.30

ROE (TTM)

DMRA-8306.0%

ORIC-3535.0%

ROA (TTM)

DMRA-7849.0%

ORIC-3339.0%

ROIC (TTM)

DMRA-8306.0%

ORIC-3535.0%

Cash

DMRA$541M

ORIC$37M

Debt

DMRA$0

ORIC$0

Net Cash/Debt

DMRA$541M

ORIC$37M

Current Ratio (TTM)

DMRA19.73x

ORIC13.19x

Quick Ratio (TTM)

DMRA19.70x

ORIC12.76x

Debt/Equity (TTM)

DMRA0.00x

ORIC0.00x

Debt/Assets (TTM)

DMRA0.0%

ORIC0.0%

Interest Coverage (TTM)

DMRAN/A

ORICN/A

Net Debt/EBITDA (TTM)

DMRA0.00x

ORIC0.00x

Beta

DMRA-4.05

ORIC1.13

52W Performance

DMRA-17.4%

ORIC-16.0%

YTD Performance

DMRA-17.4%

ORIC46.8%

% from 52W High

DMRA-39.6%

ORIC-18.3%

% from 52W Low

DMRA27.8%

ORIC65.8%

Asset Turnover (TTM)

DMRA0.00x

ORIC0.00x

FCF Yield (TTM)

DMRA-3.4%

ORIC-9.0%

Earnings Yield (TTM)

DMRA-20.4%

ORIC-11.3%

Dividend Yield (TTM)

DMRAN/A

ORICN/A

Rule of 40

DMRA0.0

ORIC0.0

EV/GP/RG

DMRAN/A

ORICN/A

Ticker research

View DMRA research View ORIC research

Metric	DMRA Damora Therapeutics Inc	ORIC Oric Pharmaceuticals Inc
Market & Valuation
Market Cap	$1.30B	$1.24B
Enterprise Value	$757M	$1.20B
Price	$21.08	$11.99
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.47x	3.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.00x	-10.72x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	346.9%	1520.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-265M	$-140M
FCF (TTM)	$-45M	$-112M
EPS (TTM)	-$4.34	-$1.30
ROE (TTM)	-8306.0%	-3535.0%
ROA (TTM)	-7849.0%	-3339.0%
ROIC (TTM)	-8306.0%	-3535.0%
Financial Health
Cash	$541M	$37M
Debt	$0	$0
Net Cash/Debt	$541M	$37M
Current Ratio (TTM)	19.73x	13.19x
Quick Ratio (TTM)	19.70x	12.76x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-4.05	1.13
52W Performance	-17.4%	-16.0%
YTD Performance	-17.4%	46.8%
% from 52W High	-39.6%	-18.3%
% from 52W Low	27.8%	65.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-3.4%	-9.0%
Earnings Yield (TTM)	-20.4%	-11.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DMRA research	View ORIC research

Valuation

P/S Ratio

DMRA

0.00x

ORIC

0.00x

EV/FCF

DMRA

-17.00x

ORIC

-10.72x

Growth & revenue

Forward Revenue Growth

ORIC

1520.7%

DMRA

346.9%

Profitability & performance

Gross Margin

DMRA

0.0%

ORIC

0.0%

ROE

ORIC

-3535.0%

DMRA

-8306.0%

FCF Yield %

DMRA

-3.4%

ORIC

-9.0%

52-Week Performance

ORIC

-16.0%

DMRA

-17.4%

Detailed metrics comparison

DMRA

Damora Therapeutics Inc

ORIC

Oric Pharmaceuticals Inc

Market Cap

DMRA$1.30B

ORIC$1.24B

Enterprise Value

DMRA$757M

ORIC$1.20B

Price

DMRA$21.08

ORIC$11.99

P/E Ratio

DMRAN/A

ORICN/A

P/S Ratio

DMRA0.00x

ORIC0.00x

EV/Sales

DMRA0.00x

ORIC0.00x

EV/EBITDA

DMRA0.00x

ORIC0.00x

P/B Ratio

DMRA2.47x

ORIC3.32x

P/FCF Ratio

DMRAN/A

ORICN/A

EV/FCF

DMRA-17.00x

ORIC-10.72x

PEG Ratio

DMRAN/A

ORICN/A

Forward P/E (NTM)

DMRAN/A

ORICN/A

Forward P/S (NTM)

DMRAN/A

ORICN/A

Revenue (TTM)

DMRA$0

ORIC$0

Revenue Growth (YoY)

DMRAN/A

ORICN/A

Forward Rev Growth

DMRA346.9%

ORIC1520.7%

Gross Margin (TTM)

DMRA0.0%

ORIC0.0%

Operating Margin (TTM)

DMRA0.0%

ORIC0.0%

EBITDA Margin (TTM)

DMRA0.0%

ORIC0.0%

Net Margin (TTM)

DMRA0.0%

ORIC0.0%

FCF Margin (TTM)

DMRAN/A

ORICN/A

Net Income (TTM)

DMRA$-265M

ORIC$-140M

FCF (TTM)

DMRA$-45M

ORIC$-112M

EPS (TTM)

DMRA-$4.34

ORIC-$1.30

ROE (TTM)

DMRA-8306.0%

ORIC-3535.0%

ROA (TTM)

DMRA-7849.0%

ORIC-3339.0%

ROIC (TTM)

DMRA-8306.0%

ORIC-3535.0%

Cash

DMRA$541M

ORIC$37M

Debt

DMRA$0

ORIC$0

Net Cash/Debt

DMRA$541M

ORIC$37M

Current Ratio (TTM)

DMRA19.73x

ORIC13.19x

Quick Ratio (TTM)

DMRA19.70x

ORIC12.76x

Debt/Equity (TTM)

DMRA0.00x

ORIC0.00x

Debt/Assets (TTM)

DMRA0.0%

ORIC0.0%

Interest Coverage (TTM)

DMRAN/A

ORICN/A

Net Debt/EBITDA (TTM)

DMRA0.00x

ORIC0.00x

Beta

DMRA-4.05

ORIC1.13

52W Performance

DMRA-17.4%

ORIC-16.0%

YTD Performance

DMRA-17.4%

ORIC46.8%

% from 52W High

DMRA-39.6%

ORIC-18.3%

% from 52W Low

DMRA27.8%

ORIC65.8%

Asset Turnover (TTM)

DMRA0.00x

ORIC0.00x

FCF Yield (TTM)

DMRA-3.4%

ORIC-9.0%

Earnings Yield (TTM)

DMRA-20.4%

ORIC-11.3%

Dividend Yield (TTM)

DMRAN/A

ORICN/A

Rule of 40

DMRA0.0

ORIC0.0

EV/GP/RG

DMRAN/A

ORICN/A

Ticker research

View DMRA research View ORIC research

Metric	DMRA Damora Therapeutics Inc	ORIC Oric Pharmaceuticals Inc
Market & Valuation
Market Cap	$1.30B	$1.24B
Enterprise Value	$757M	$1.20B
Price	$21.08	$11.99
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.47x	3.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.00x	-10.72x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	346.9%	1520.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-265M	$-140M
FCF (TTM)	$-45M	$-112M
EPS (TTM)	-$4.34	-$1.30
ROE (TTM)	-8306.0%	-3535.0%
ROA (TTM)	-7849.0%	-3339.0%
ROIC (TTM)	-8306.0%	-3535.0%
Financial Health
Cash	$541M	$37M
Debt	$0	$0
Net Cash/Debt	$541M	$37M
Current Ratio (TTM)	19.73x	13.19x
Quick Ratio (TTM)	19.70x	12.76x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-4.05	1.13
52W Performance	-17.4%	-16.0%
YTD Performance	-17.4%	46.8%
% from 52W High	-39.6%	-18.3%
% from 52W Low	27.8%	65.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-3.4%	-9.0%
Earnings Yield (TTM)	-20.4%	-11.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DMRA research	View ORIC research